Empirical Null Estimation Using Zero-Inflated Discrete Mixture Distributions and its Application to Protein Domain Data

In recent mutation studies, analyses based on protein domain positions are gaining popularity over gene-centric approaches since the latter have limitations in considering the functional context that the position of the mutation provides. This presents a large-scale simultaneous inference problem, w...

Full description

Saved in:
Bibliographic Details
Published in:Biometrics 2018-06, Vol.74 (2), p.458-471
Main Authors: Gauran, Iris Ivy M., Park, Junyong, Lim, Johan, Park, DoHwan, Zylstra, John, Peterson, Thomas, Kann, Maricel, Spouge, John L.
Format: Article
Language:English
Subjects:
BIOMETRIC METHODOLOGY: DISCUSSION PAPER
Biometry - methods
Computer simulation
Data Interpretation, Statistical
Data processing
Databases, Protein
DNA Mutational Analysis
Empirical analysis
Humans
Local false discovery rate
Mutation
Mutation Rate
Poisson Distribution
Protein domain
Protein Domains
Proteins
Statistical Distributions
Zero‐in ated generalized poisson
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In recent mutation studies, analyses based on protein domain positions are gaining popularity over gene-centric approaches since the latter have limitations in considering the functional context that the position of the mutation provides. This presents a large-scale simultaneous inference problem, with hundreds of hypothesis tests to consider at the same time. This article aims to select significant mutation counts while controlling a given level of Type I error via False Discovery Rate (FDR) procedures. One main assumption is that the mutation counts follow a zero-inflated model in order to account for the true zeros in the count model and the excess zeros. The class of models considered is the Zero-inflated Generalized Poisson (ZIGP) distribution. Furthermore, we assumed that there exists a cut-off value such that smaller counts than this value are generated from the null distribution. We present several data-dependent methods to determine the cut-off value. We also consider a two-stage procedure based on screening process so that the number of mutations exceeding a certain value should be considered as significant mutations. Simulated and protein domain data sets are used to illustrate this procedure in estimation of the empirical null using a mixture of discrete distributions. Overall, while maintaining control of the FDR, the proposed two-stage testing procedure has superior empirical power.
ISSN:0006-341X
1541-0420
DOI:10.1111/biom.12779